Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Godavari Lifesciences Ltd
NSE: GODAVARILSBSE: 548248Pharma Formulations
₹883.50
▲ 4.70 (+0.53%)
Cash Flow
- FY22: 528
- FY23: 563
- FY24: 670
- FY25: 838
- FY26: 1,190
- FY22: -237
- FY23: -352
- FY24: -429
- FY25: -544
- FY26: -588
- FY22: -173
- FY23: -116
- FY24: -85
- FY25: -369
- FY26: 42
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 528 | 563 | 670 | 838 | 1,190 |
| Capital expenditure | -237 | -352 | -429 | -544 | -588 |
| Cash from investing activity | -239 | -365 | -477 | -585 | -612 |
| Cash from financing activity | -462 | -314 | -278 | -622 | -536 |
| Net cash flow | -173 | -116 | -85 | -369 | 42 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 10 periods. Premium unlocks the full 10-year history. See Premium